Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
SCOLR PHARMA, Inc. Add to My Watchlist (AMEX: DDD) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     SCOLR PHARMA 0.58 - (+0.00%) -
3625 132nd Avenue S.E.
Suite 400
Bellevue, WA 98006 US
(425) 373-0171
(425) 373-0181 fax
www.scolr.com
CEO Stephen J. Turner
Auditor GRANT THORNTON LLP
Exchange Traded AM
ISIN Number US78402X1072
CIK Number 934936
NAICS Code 325413
Business Summary
A pharmaceutical company, which develops and formulates over-the-counter products, prescription drugs and dietary supplement products using its controlled delivery technology platform.
Number of Employees 17
Share Fundamentals
Market Cap 23.84M
Shares Outstanding 41.10M
Float 38.22M
Short Interest 39.11K
Financial Strength
Revenue (TTM) $841,651
Earnings (TTM) -$7,986,686
Quick Ratio 3.3:1
Current Ratio 3.8:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Market News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs